Hospital Stewardship Dashboards: From Alerts to Outcomes
Hospitals generate vast amounts of antimicrobial prescribing data, but turning that data into actionable insight remains a challenge. Antibiotic stewardship programs often rely on manual
Hospitals generate vast amounts of antimicrobial prescribing data, but turning that data into actionable insight remains a challenge. Antibiotic stewardship programs often rely on manual
Antibiotic resistance is fueled not only by overprescribing but also by how patients use medicines once they leave the clinic. Skipped doses, delayed intakes, or
Author: Sylvia (Xi) He – Medical / Scientific Editor & Writer Cialis (tadalafil) is widely recognized for its long half-life and flexible dosing, making it
Author: Sylvia (Xi) He – Medical / Scientific Editor & Writer Introduction Tadalafil, the long-acting phosphodiesterase type 5 inhibitor (PDE5i) better known by its brand
Introduction: The New Landscape of Male Pattern Hair Loss Management For millions of men with androgenetic alopecia, also known as male pattern hair loss, the
Introduction: pharmacogenomics 101 for PDE5 Inhibitors While sildenafil is widely effective for erectile dysfunction and pulmonary hypertension, its pharmacokinetic variability remains a clinical challenge. Standard
Sildenafil’s therapeutic applications now extend far beyond erectile dysfunction, including indications in pulmonary hypertension, HFpEF, and off-label cardiovascular use. Yet its metabolic vulnerability to CYP3A
Introduction: The CKD Polypharmacy Burden Chronic kidney disease (CKD) often demands complex medication regimens. Patients commonly take losartan, metformin, SGLT2 inhibitors, and additional agents for
Introduction: Why Formulation Still Matters Though sildenafil remains the leading oral treatment for erectile dysfunction, its conventional film-coated tablet (FCT) form has drawbacks: delayed onset,
Digital Weight Management Platforms + Ozempic: Behavioural ‘Glue’ for GLP-1 Success Introduction: Why Lifestyle Support Still Matters The success of semaglutide-based therapies like Ozempic in